New Concepts Under FTC Rule For Pharma Patent Deals
The Federal Trade Commission recently announced and asked for comments on proposed changes to the premerger notification rules under the Hart-Scott-Rodino Act. The proposed rules would require pharmaceutical companies to report...To view the full article, register now.
Already a subscriber? Click here to view full article